Wolfgang Mueck
Wuppertal, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 45 publications
Population pharmacokinetic analysis of rivaroxaban in children and comparison to prospective physiologically-based pharmacokinetic predictions.
Journal: CPT: pharmacometrics & systems pharmacology
Published: April 01, 2021
Safety, pharmacodynamic, and pharmacokinetic characterization of vericiguat: results from six phase I studies in healthy subjects.
Journal: European journal of clinical pharmacology
Published: June 08, 2020
Metabolism and Pharmacokinetic Drug-Drug Interaction Profile of Vericiguat, A Soluble Guanylate Cyclase Stimulator: Results From Preclinical and Phase I Healthy Volunteer Studies.
Journal: Clinical pharmacokinetics
Published: May 28, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism.
Journal: Journal of thrombosis and thrombolysis
Published: April 24, 2020
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism.
Journal: Journal of thrombosis and thrombolysis
Published: April 24, 2020
Applications of Physiologically Based Pharmacokinetic Modeling of Rivaroxaban-Renal and Hepatic Impairment and Drug-Drug Interaction Potential.
Journal: Journal of clinical pharmacology
Published: February 27, 2020
Pharmacokinetic interaction of riociguat and antiretroviral combination regimens in HIV-1-infected adults.
Journal: Pulmonary circulation
Published: April 19, 2019
Enhancing the Quality of Rivaroxaban Exposure Estimates Using Prothrombin Time in the Absence of Pharmacokinetic Sampling.
Journal: CPT: pharmacometrics & systems pharmacology
Published: January 17, 2019
Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study.
Journal: Thrombosis journal
Published: September 05, 2018
Clinical Pharmacokinetic and Pharmacodynamic Profile of Riociguat.
Journal: Clinical pharmacokinetics
Published: November 01, 2017
Integrated Population Pharmacokinetic Analysis of Rivaroxaban Across Multiple Patient Populations.
Journal: CPT: pharmacometrics & systems pharmacology
Published: October 09, 2017
Last Updated: 09/26/2026